Prostate cancer Board decisions

The veteran's disability rating for prostate cancer was reduced from 100 percent to 20 percent effective October 1, 2002. The appeal is denied as the reduction was proper.

The Board has remanded the case due to a violation of Stegall v. West, and additional medical evidence was added without review by the RO.

The veteran's claim for service connection for prostate cancer was granted on a presumptive basis due to exposure to herbicide agents, effective from November 7, 1996. The appellant is seeking an earlier effective date.

The veteran's appeal for service connection for prostate cancer as a result of exposure to ionizing radiation is dismissed due to his death during the pendency of the appeal.

The Board found no evidence of prostate cancer in the veteran's service or post-service medical records, and thus denied his claim for service connection.

The veteran's service is not considered valid, and therefore he does not have basic eligibility for VA disability compensation benefits or special monthly pension.

The veteran's service-connected residuals of prostate cancer are restored to a 100 percent rating effective June 18, 2003.

The veteran's residuals of prostate cancer, which include urinary incontinence requiring the use of absorbent materials changed more than four times per day, are rated at a maximum of 60 percent.

The veteran's prostate cancer residuals have been rated at 40 percent since June 2, 2002.

The Board denied the appellant's claim for service connection for the cause of her husband's death, finding that there was no evidence to support a link between his prostate and lung cancers and his military service.

The Board found that the veteran's basal cell carcinoma and prostate cancer did not become manifest during service or within presumptive periods, and thus denied service connection for these conditions.

The RO has reduced the veteran's prostate cancer rating from 100 percent to 10 percent. The case is being remanded for further development and review.

The veteran's claim for an increased rating for prostate cancer is being remanded due to the need for additional development and consideration of newly obtained VA examination results and treatment records.

The Board has ordered the RO to obtain updated financial information and health condition details from the veteran. The overpayment amount may be adjusted based on this new information, and the waiver of recovery will then be reconsidered.

The Board denied the veteran's claims for service connection for prostate cancer and an initial compensable evaluation for varicose veins of the right lower extremity, finding that there was no evidence to support these claims.

The Board has reopened the veteran's claim of service connection for hypertension, to include as due to his service-connected auriculoventricular heart block with myocardial damage. The new evidence submitted suggests a possible relationship between hypertension and previous heart damage.

The Board has granted an increased evaluation of 40% for prostate cancer secondary to Agent Orange exposure, effective from the date of the decision.

The Board denied the veteran's claims of service connection for various conditions, finding that there was no evidence to support a nexus between his claimed disabilities and his military service.

The Board denied the veteran's claim for service connection for prostate cancer, which he claimed was due to exposure to ionizing radiation during his military service. The VA determined that there is no reasonable possibility that the veteran's prostate cancer can be attributed to such exposure.